Feature | SCAI | May 01, 2017

Late-Breaking Clinical Trial Presentations at SCAI 2017

a list of SCAI late breaking trial presentations

May 30, 2017 — The Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions took place May 10-13, 2017 in New Orleans. The annual meeting included several late-breaking presentations on the latest advances in interventional cardiology. Article links are included for the key presentations.

 

Late-breaking Study Presentations

Adventitial Dexamethasone Reduces Inflammatory Biomarker Levels After Peripheral Artery Balloon Angioplasty or Atherectomy: Results from the DANCE Trial. Presented by Ehrin J. Armstrong, M.D., MSc, MAS, FSCAI.

CD34+ Stem Cell Therapy Improves Exercise Time and Mortality in Refractory Angina: A Patient Level Meta-Analysis. Presented by Thomas J. Povsic, M.D., Ph.D.

Effect of Bivalirudin Versus Unfractionated Heparin in Patients with Baseline or New-Onset Atrial Fibrillation in Transcatheter Aortic Valve Replacement: From the BRAVO-3 Randomized Trial. Presented by Anita W. Asgar

Clopidogrel Response Evaluation and Anti-Platelet Intervention in High Thrombotic Risk PCI Patients (CREATIVE trial). Presented by Yida Tang, M.D., Ph.D., FSCAI.

Impact of Valve Design and Bivalirudin vs. Unfractionated Heparin for Anticoagulation in Transcatheter Aortic Valve Replacement: Results from the BRAVO-3 trial. Presented by Axel Linke, M.D.

Interaction Effects of Race/Ethnicity and Sex on Outcomes after PCI: A Subanalysis of the PLATINUM Diversity study. Presented by Wayne B. Batchelor, M.D., MHS, FSCAI.

Outcomes of Early vs. Late Revascularization in Low and High Risk Patients Hospitalized with Non ST-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study. Presented by Sameer Arora, M.D., at 11:30 a.m. 

Efficacy and Safety Outcomes of Radial vs. Femoral-Access Robotic Percutaneous Coronary Intervention: Final Results of the Multicenter PRECISION Registry. Presented by Ehtisham Mahmud, M.D., FSCAI.

• Day of the Week PCI-Related Hospitalization Occurs Determines Likelihood of Survival. Presented by Byomesh Tripathi, M.D.

 

SCAI Video Coverage

Watch VIDEO coverage of key SCAI 2017 news, courses and trials at www.youtube.com/playlist?list=PLYpLxw1Ganwa5kJFa3TrFAY5l1-Jeu9Ax

 

Late-breaking Trials From TCT and ACC: 

ACC 2017 Late-Breaking Trials

TCT 2016 Late-breaking Trials and First Reports

 

For more information: www.scai.org/SCAI2017/default.aspx

Related Content

Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
Overlay Init